59 Episoder

  1. What's wrong with US healthcare and how startups can fix it, with Justin Mares

    Publisert: 17.4.2025
  2. Frontier investable areas in brain health with PsyMed Ventures

    Publisert: 25.2.2025
  3. Temporal Interference: The Future of Brain Stimulation with Nir Grossman

    Publisert: 30.1.2025
  4. The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.

    Publisert: 26.12.2024
  5. The State of Autism Part 1 with Elizabeth Horn of 2m Foundation

    Publisert: 12.12.2024
  6. Genetic Medicine for Brain Health with Dana Watt of Breakout Ventures

    Publisert: 14.11.2024
  7. Transcranial Focused Ultrasound for Mental Health with Jay Sanguinetti of Sanmai

    Publisert: 5.9.2024
  8. Navigating FDA clinical trials in Neurotech with Tim Marjenin

    Publisert: 23.8.2024
  9. Environmental Toxins and Mental Health with Gurdane Bhutani

    Publisert: 18.7.2024
  10. FDA advisors say no to MDMA. What’s the impact? With Josh Hardman

    Publisert: 21.6.2024
  11. Investing in New Frontiers of Mental Health (Live at SXSW)

    Publisert: 7.5.2024
  12. Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF)

    Publisert: 9.4.2024
  13. What Payers Want with Lili Brillstein

    Publisert: 14.3.2024
  14. Decoding the Brain with Ed Boyden

    Publisert: 22.2.2024
  15. 5-MeO-DMT in mental healthcare with Steve Rio

    Publisert: 25.1.2024
  16. Tom Insel: Startups, AI, Psychedelics, and SSRIs

    Publisert: 15.12.2023
  17. Food as Medicine for Mental Health: Drew Ramsey

    Publisert: 30.11.2023
  18. Ketogenic Diet for Brain Health: Jan Baszucki

    Publisert: 16.11.2023
  19. Investing in Neurotech 101: Alex Morgan of Khosla Ventures

    Publisert: 2.11.2023
  20. All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression

    Publisert: 20.10.2023

1 / 3

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Visit the podcast's native language site